Claybrook Capital’s Zoetis ZTS Stock Holding History

Claybrook Capital’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,416	Closed	-$121K	–	715
2018 Q4	$121K	Buy	+1,416	New	+$128K	0.03%	178

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Claybrook Capital's ZTS Position: Q1 2019 in Review

Claybrook Capital sold out of Zoetis (ZTS) in Q1 2019, closing a stake of 1,416 shares — an estimated $121K sold.

Claybrook Capital first reported a position in ZTS in Q4 2018 and held it in 1 quarter. The position peaked at $121K in Q4 2018. 1,041 funds tracked by Wall St. Rank hold ZTS as of Q1 2019.

Claybrook Capital reported no remaining Zoetis position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 1,416 Zoetis shares in Q1 2019, an estimated $121K.
Claybrook Capital first reported a position in Zoetis in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Zoetis position peaked at $121K in Q4 2018.
1,041 funds tracked by Wall St. Rank held Zoetis as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.